Blood pressure drug losartan recall expanded
If you take any blood pressure medicine, you will want to double-check your bottle. Torrent Pharmaceuticals Ltd. has expanded the recall of losartan potassium/hydrochlorothiazide and losartan potassium based medicines.
Several tests found trace amounts of a potentially cancer causing impurity called N-methylnitrosobutyric acid in a few of these drugs. The company said on Thursday that it is recalling 36 additional lots.
The list of recalled drugs is available on the US Food and Drug Administration website.
Though the drug manufacturer company hasn’t got reports of any of the users getting sick, the impurity level in these pills is higher than what the FDA considers an acceptable daily intake level.
Doctors and physicians prescribe losartan for patients who have high blood pressure and for Type 2 diabetics who have nephropathy. The FDA has advised patients who take these drugs, even those who take the ones that have been recalled to continue taking them, but to consult their doctor or pharmacist immediately about any alternative treatment.
This latest recall is related to the valsartan recall which has been expanded multiple times since July last year. The FDA has put the Chinese company Zhejiang Huahai Pharmaceutical on an import alert after it came to know that the company made the tainted ingredient that is at the heart of most of these recalls.
A chemical that is used in gasoline as a stabilizer and as a lubricant additive was found in these medicines.